Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia
- 1 June 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 115 (6) , 1233-1238
Abstract
OBJECTIVE: To estimate the ability of maternal serum markers and uterine artery Doppler in predicting preeclampsia. METHODS: In this nested case–control study, maternal serum concentrations of cystatin C, β2-microglobulin, serum amyloid A, C-reactive protein (CRP), and neopterin were measured, and resistance index of uterine artery blood flow was assessed in 45 women in whom preeclampsia subsequently developed and in 125 women with normal pregnancy outcome. Univariable regression analysis was performed to estimate correlations between serum markers and resistance index for the development of preeclampsia. Significant variables were identified using multiple logistic regressions. RESULTS: Maternal serum markers were measured at a median gestational age of 14.7 weeks (interquartile range 3.1) in control group members and 16.3 weeks (interquartile range 4.8) in the case group members, and uterine resistance index was measured at the second-trimester scan. Univariable logistic regression showed that women with subsequent preeclampsia had increased levels of cystatin C, β2-microglobulin, neopterin, CRP, and resistance index. Cystatin C, CRP, and resistance index remained independently associated with preeclampsia when multiple logistic regression was applied. Receiver-operating characteristic curve analysis showed that a combination of markers had a better area under the curve (AUC; 0.825) than when used in isolation (cystatin C, AUC 0.725; CRP, AUC 0.634; resistance index, AUC 0.728). Sensitivity of uterine artery resistance index, cystatin C, and CRP combined for predicting preeclampsia was 69.2% for a screen-positive rate of 15%. CONCLUSION: Maternal serum cystatin C, CRP, and uterine artery mean resistance index are independent predictors of preeclampsia. There is improved prediction of preeclampsia when serum markers are combined with Doppler indices.Keywords
This publication has 30 references indexed in Scilit:
- Predicting and preventing pre‐eclampsia—where to next?Ultrasound in Obstetrics & Gynecology, 2008
- Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient dataThe Lancet, 2007
- Uterine artery Doppler in the prediction of adverse pregnancy outcomeCurrent Opinion in Obstetrics and Gynecology, 2007
- Vitamins C and E and the Risks of Preeclampsia and Perinatal ComplicationsNew England Journal of Medicine, 2006
- Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trialThe Lancet, 2006
- World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant womenAmerican Journal of Obstetrics and Gynecology, 2006
- Pre-eclampsiaThe Lancet, 2005
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestationObstetrics & Gynecology, 2000